A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.

Jacques BalossoOlivia Febvey-CombesAnnie IungHélène LozanoAbdoulkader Soumai AllohCatherine CornuMagali HervéZohra AkkalMichel LièvreValérie PlattnerFrancesca ValvoCristina BonoMaria Rosaria FioreViviana VitoloBarbara VischioniStéphanie PatinHubert AllemandFrançois GueyffierJennifer MargierPascale GuerreSylvie ChabaudRoberto OrecchiaPascal Pommier

Published in: BMC cancer (2022)

ClinicalTrials.gov identifier: NCT02838602 . Date of registration: July 20, 2016. The posted information will be updated as needed to reflect protocol amendments and study progress.

Keyphrases

phase iii
clinical trial
open label
phase ii
early stage
radiation induced
social media
placebo controlled